Aurlumyn Disease Interactions
There are 2 disease interactions with Aurlumyn (iloprost).
Iloprost (applies to Aurlumyn) hypotension
Major Potential Hazard, Moderate plausibility.
Iloprost should not be initiated in patients with systolic blood pressure below 85 mmHg. The risk of syncope in association with physical exertion can occur in pulmonary arterial hypertension and the occurrence may reflect a therapeutic gap or insufficient efficacy. The need to adjust dose or change therapy should be considered. It is recommended to monitor vital signs when initiating treatment with iloprost in patients at risk.
Iloprost (applies to Aurlumyn) bronchospasm
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Pulmonary Impairment
Iloprost can induce bronchospasm and may be more severe or frequent in patients with history of hyperreactive airways. Close monitoring is recommended when using iloprost in patients with chronic obstructive pulmonary disease, severe asthma, or with acute pulmonary infections.
Switch to professional interaction data
Aurlumyn drug interactions
There are 298 drug interactions with Aurlumyn (iloprost).
Report options
More about Aurlumyn (iloprost)
- Aurlumyn consumer information
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
